Widespread pharmacogenomic testing in psychiatry needs a stronger evidence base More research into the genomic factors influencing psychiatric medicines response is needed before widespread pharmacogenomic testing can be justified.…
Expanded genetic profiling could guide cancer treatment, study finds Researchers analysed whole-genome data with data from the NHS, revealing genetic changes in cancers that may affect survival rates and patient outcomes.…
Geraldine McCaffrey: ‘The advances we’re making in Wales are really exciting’ The recently elected chair of the Royal Pharmaceutical Society’s Welsh Pharmacy Board talks to The Pharmaceutical Journal about the Society’s role in assisting the evolving workforce in Wales.…
Pharmacists asked for views on implementing pharmacogenetics in the NHS Participants in a survey will be presented with a series of hypothetical options related to using pharmacogenetics in the prescribing process, as part of a pilot programme.…
Clopidogrel may be less effective in British South Asian patients, study results suggest The study authors concluded that non-CYP2C19-dependent antiplatelet agents would likely have a "disproportionate benefit" in the British South Asian population.…
Only pharmacists have signed up to postgraduate pharmacogenomics course Exclusive: The course, run by Bangor University, had 16 participants in its first year, all of whom were pharmacists.…
Genetic ‘biobank’ version of Yellow Card scheme to be piloted by drugs regulator Genetic data and samples from patients who have experienced adverse side effects to medicines will be stored in the biobank, which will be used to determine whether the reaction was the result of a genetic trait.…
PJ view: a pharmacogenomic revolution is gathering pace There has been rapid progress in the use of pharmacogenomics in patient care over the past 18 months — and it appears to be just the start.…
NICE to recommend genetic testing before prescribing clopidogrel The National Institute for Health and Care Excellence has said genetic testing before initiating clopidogrel is a cost-effective use of NHS resources for patients at risk of stroke.…
Pharmacogenomic testing pilot to start in general practice from June 2023 The pilot will test patients when they start a new statin, certain antidepressants or proton pump inhibitors to ensure they are on the right medication and not at risk of side effects.…
